The ultrasound DVT pathway has been updated to include a stat dose of 15mg oral Rivaroxaban where there is a delay >6 hours to ultrasound. This is an alternative to administering Clexane.
Ensure to check contraindications and cautions - see link here for the Ultrasou...
Rivaroxaban funding
September 17, 2018
Rivaroxaban not indicated or funded before POAC DVT scan
In line with the Auckland Regional HealthPathway, when there is a delay in obtaining community ultrasound for DVT, Enoxaparin continues to be the medication to be administered and funded through POAC.
The issue of using rivaroxaban instead of enoxaparin for anticoagulation c...
TAGS
abscesscellulitisdvtECGCOVID19OSTRivaroxabanTroponinACSAcute ECGantibioticBARTHOLIN'S ABSCESSboilBREAST ABSCESScephazolinChest PainclexaneCOVIDCXRcystdehydrationdentalectopicFAQsFerinjectgynaeHep CHepatitisINRIVIV ironmaternityMaviretNurse Advisorovarianovarian cystovarian torsionpaediatric cellulitispelvic painpelvic scanpelvic ussPIDPOACPOAC ECGpoac pelvic\Sarah Hydersore throattonsilitistoothachewells scoreX ray and COVID swabXray